GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes 1. In this cohort of individuals with type 2 diabetes (T2D), use of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a slightly increased risk of developing diabetic retinopathy (DR); however, it is also associated with fewer severe vision-threatening complications. Evidence […]